ESC 2018 - PACE-CME

1-16 of 18

Screening for high blood pressure globally
Screening for high blood pressure globally
ESC 2018
Screening for high blood pressure globally
Dr. Thomas Beaney
- Dr. Thomas Beaney
Long term benefits of antihypertensive and cholesterol-lowering treatment in hypertension
Long term benefits of antihypertensive and cholesterol-lowering treatment in hypertension
ESC 2018
Long term benefits of antihypertensive and cholesterol-lowering treatment in hypertension
Dr. Ajay Gupta
- Dr. Ajay Gupta
Shared decision-making with lifetime risk model
Shared decision-making with lifetime risk model
ESC 2018
Shared decision-making with lifetime risk model
Dr. Jannick Dorresteijn
- Dr. Jannick Dorresteijn
The predictive role of biomarkers in CV risk assessment
The predictive role of biomarkers in CV risk assessment
ESC 2018
The predictive role of biomarkers in CV risk assessment
Nina Paynter, PhD
- Nina Paynter, PhD
Women are not a subgroup: the importance of sex-specific analyses
Women are not a subgroup: the importance of sex-specific analyses
ESC 2018
Women are not a subgroup: the importance of sex-specific analyses
Dr. Jeanine Roeters van Lennep
- Dr. Jeanine Roeters van Lennep
Surprising result: Association very high levels of HDL-c and increased risk of CV events
Surprising result: Association very high levels of HDL-c and increased risk of CV events
ESC 2018
Surprising result: Association very high levels of HDL-c and increased risk of CV events
Dr. Marc P Allard-Ratick
- Dr. Marc P Allard-Ratick
Higher healthy diet score is associated with a lower risk of mortality and CV events across the globe
Higher healthy diet score is associated with a lower risk of mortality and CV events across the globe
ESC 2018
Higher healthy diet score is associated with a lower risk of mortality and CV events across the globe
Andrew Mente, MSc, PhD
- Andrew Mente, MSc, PhD
Neutral outcomes for early intervention strategy compared to standard strategy in NSTEMI patients
Neutral outcomes for early intervention strategy compared to standard strategy in NSTEMI patients
ESC 2018
Neutral outcomes for early intervention strategy compared to standard strategy in NSTEMI patients
Prof. Thomas Engstrom
- Prof. Thomas Engstrom
Can sex-specific thresholds for hs-troponin improve diagnosis of myocardial infarction?
Can sex-specific thresholds for hs-troponin improve diagnosis of myocardial infarction?
ESC 2018
Can sex-specific thresholds for hs-troponin improve diagnosis of myocardial infarction?
Prof. Nicholas Mills
- Prof. Nicholas Mills
In a primary prevention setting of diabetes patients, aspirin did not give overall benefit
In a primary prevention setting of diabetes patients, aspirin did not give overall benefit
ESC 2018
In a primary prevention setting of diabetes patients, aspirin did not give overall benefit
Prof. Jane Armitage
- Prof. Jane Armitage
P2Y12 inhibitor monotherapy for 23 months after 1 month of DAPT, compared to traditional 12-month DAPT
P2Y12 inhibitor monotherapy for 23 months after 1 month of DAPT, compared to traditional 12-month DAPT
ESC 2018
P2Y12 inhibitor monotherapy for 23 months after 1 month of DAPT, compared to traditional 12-month DAPT
Prof. Patrick Serruys
- Prof. Patrick Serruys
Direct Factor Xa inhibitor does not mitigate worsening of heart failure in HFrEF patients
Direct Factor Xa inhibitor does not mitigate worsening of heart failure in HFrEF patients
ESC 2018
Direct Factor Xa inhibitor does not mitigate worsening of heart failure in HFrEF patients
Prof. Faiez Zannad, MD
- Prof. Faiez Zannad, MD
Impressive results with transthyretin-stabilizer that reduces mortality and hospitalization in patients with transthyretin-related cardiomyopathy
Impressive results with transthyretin-stabilizer that reduces mortality and hospitalization in patients with transthyretin-related cardiomyopathy
ESC 2018
Impressive results with transthyretin-stabilizer that reduces mortality and hospitalization in patients with transthyretin-related cardiomyopathy
Prof. Claudio Rapezzi
- Prof. Claudio Rapezzi
Weight loss agent showed CV safety in high-risk patients with overweight or obesity
Weight loss agent showed CV safety in high-risk patients with overweight or obesity
ESC 2018
Weight loss agent showed CV safety in high-risk patients with overweight or obesity
Dr. Erin Bohula
- Dr. Erin Bohula
What is the situation one year after the presentation about the CANTOS trial?
What is the situation one year after the presentation about the CANTOS trial?
ESC 2018
What is the situation one year after the presentation about the CANTOS trial?
Paul Ridker, MD
- Paul Ridker, MD
No CV benefit with omega-3 fatty acid supplements
No CV benefit with omega-3 fatty acid supplements
ESC 2018
No CV benefit with omega-3 fatty acid supplements

Prev
1
2
Next

1/2